Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri

International Journal of Antimicrobial Agents

Volumn 32, Issue 5, 2008, Pages 411-417

  Kim, Jong Hyun ^a   Lee, Yang Jin ^a   Sohn, Hae Jin ^a   Song, Kyoung Ju ^a   Kwon, Daeho ^a   Kwon, Myung Hee ^a   Im, Kyung Il ^b   Shin, Ho Joon ^a  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Naegleria fowleri; PAME; Rokitamycin

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; HYGROMYCIN B; LACTATE DEHYDROGENASE; NEOMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; ROKITAMYCIN; ROXITHROMYCIN; UNCLASSIFIED DRUG; ZEOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; DOSE LIVER FUNCTION RELATION; DRUG CYTOTOXICITY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; ENZYME RELEASE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER TOXICITY; MENINGOENCEPHALITIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NAEGLERIA FOWLERI; NEPHROTOXICITY; NONHUMAN; PRIMARY AMOEBIC MENINGOENCEPHALITIS; PRIORITY JOURNAL; SURVIVAL RATE; TIME OF DEATH; TROPHOZOITE; UREA NITROGEN BLOOD LEVEL;

AMEBIASIS; AMEBICIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD UREA NITROGEN; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; FEMALE; KIDNEY; L-LACTATE DEHYDROGENASE; LIVER; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MIOCAMYCIN; NAEGLERIA FOWLERI; SURVIVAL ANALYSIS;

EID: 53249147140     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.05.018     Document Type: Article

References (34)

1. Fowler M., and Carter R.F. Acute pyogenic meningoencephalitis probably due to Acanthamoeba sp.: a preliminary report. BMJ 3 (1965) 740-742
2. Carter R.F. Primary amoebic meningoencephalitis: clinical, pathological and epidemiological features of six fatal cases. J Pathol Bacteriol 96 (1968) 1-25
3. Carter R.F. Description of a Naegleria species isolated from two cases of primary amoebic meningoencephalitis and of the experimental pathological changes induced by it. J Pathol 100 (1970) 217-244
4. Carter R.F. Primary amoebic meningoencephalitis. An appraisal of present knowledge. Trans R Soc Trop Med Hyg 66 (1972) 193-213
5. Ferrante A. Comparative sensitivity of Naegleria fowleri to amphotericin B and amphotericin B methyl ester. Trans R Soc Trop Med Hyg 76 (1982) 476-478
6. Schuster F.L., and Visvesvara G.S. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 34 (2004) 1001-1027
7. Tiewcharoen S., Junnu V., and Suvoutho S. Effect of antifungal drugs on pathogenic Naegleria spp. isolated from natural water sources. J Med Assoc Thai 86 (2003) 876-882
8. Mattana A., Biancu G., Alberti L., Accardo A., Delogu G., Fiori P.L., et al. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii. Antimicrob Agents Chemother 48 (2004) 4520-4527
9. Goswick S.M., and Brenner G.M. Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother 17 (2003) 524-528
10. Schuster F.L., Guglielmo B.J., and Visvesvara G.S. In vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol 53 (2006) 121-126
11. Goodman J.S., and Koenig M.G. Amphotericin B-specifics of administration. Mod Treat 7 (1970) 581-595
12. McCurdy D.K., Frederic M., and Elkinton J.R. Renal tubular acidosis due to amphotericin B. N Engl J Med 278 (1968) 124-130
13. Proffitt R.T., Satorius A., Chiang S.M., Sullivan L., and Adler-Moore J.P. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 28 Suppl B (1991) 49-61
14. Stevens A.R., Shulman S.T., Lansen T.A., Cichon M.J., and Willaert E. Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies. J Infect Dis 143 (1981) 193-199
15. Hardy D.J., Hensey D.M., Beyer J.M., Vojtko C., McDonald E.J., and Fernandes P.B. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 32 (1988) 1710-1719
16. Hardy D.J., Guay D.R., and Jones R.N. Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview. Diagn Microbiol Infect Dis 15 (1992) 39-53
17. Gonzalez A., Jimenez A., Vazquez D., Davies J.E., and Schindler D. Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes. Biochim Biophys Acta 521 (1978) 459-469
18. Davis B.D. Mechanism of bactericidal action of aminoglycosides. Microbiol Rev 51 (1987) 341-350
19. Jones R.N., and Wilson H.W. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials. Diagn Microbiol Infect Dis 1 (1983) 71-83
20. Braga P.C. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides. J Chemother 14 (2002) 115-131
21. Calmels T.P., Martin F., Durand H., and Tiraby G. Proteolytic events in the processing of secreted proteins in fungi. J Biotechnol 17 (1991) 51-66
22. Willaert E. Isolement et culture in vitro des amibes de genre Naegleria. Ann Soc Belg Med Trop 51 (1971) 701-708
23. Jeong S.R., Kang S.Y., Lee S.C., Song K.J., Im K.I., and Shin H.J. Decreasing effect of an anti-Nfa1 polyclonal antibody on the in vitro cytotoxicity of pathogenic Naegleria fowleri. Korean J Parasitol 42 (2004) 35-40
24. Vargas-Zepeda J., Gomez-Alcala A.V., Vasquez-Morales J.A., Licea-Amaya L., De Jonckheere J.F., and Lares-Villa F. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res 36 (2005) 83-86
25. Wang A., Kay R., Poon W.S., and Ng H.K. Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong. Clin Neurol Neurosurg 95 (1993) 249-252
26. Goswick S.M., and Brenner G.M. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. J Parasitol 89 (2003) 837-842
27. Gupta S., Ghosh P.K., Dutta G.P., and Vishwakarma R.A. In vivo study of artemisinin and its derivatives against primary amebic meningoencephalitis caused by Naegleria fowleri. J Parasitol 81 (1995) 1012-1013
28. R in transgenic mice causes resistance to toxic effects of hygromycin B in vivo. J Pharmacol Exp Ther 281 (1997) 992-997
29. Soejima R., Hino J., Nakagawa Y., Kishimoto T., and Matsumoto A. A study of antichlamydial effect of rokitamycin. Jpn J Antibiot 41 (1988) 830-835
30. Cinco M., Padovan D., Stinco G., and Trevisan G. In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferi. Antimicrob Agents Chemother 39 (1995) 1185-1186
31. Hiramatsu K., Murakami J., Kishi K., Hirata N., Yamasaki T., Kadota J., et al. Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection. Int J Antimicrob Agents 21 (2003) 471-477
32. Cenci L., Nettis E., Berteramo R., and Ferrannini A. Rokitamycin tolerance in patients with adverse reactions to chemotherapeutic agents. Clin Ter 147 (1996) 621-626 [in Italian]
33. Yamashita N., Oikawa T., and Osano M. Studies on plasma levels and clinical efficacy of rokitamycin in pediatrics. Jpn J Antibiot 41 (1988) 739-744
34. Broggini M., Bottà V., Benvenuti C., Fonio W., Congedo M., and Parini J. Pharmacokinetics of rokitamycin after single administration to healthy volunteers. Eur J Drug Metab Pharmacokinet 16 (1991) 137-140